Group items tagged

Dengue vaccines are used to prevent dengue fever in humans. Dengue fever is a mosquito-borne tropical disease caused by the dengue virus.

The term cryptococcosis refers to a potentially fatal fungal disease caused by a few species of Cryptococcus. It was first identified by German physicians in the late nineteenth century. Some patients with cryptococcal meningitis experience a severe headache accompanied by fever, joint pain, vomiting, or anorexia.

A pulse oximeter is typically used for target diseases, which include measles, tuberculosis, tetanus, etc. Recently, hepatitis B and yellow fever have also been added to the list of the target diseases.

Primary biliary cholangitis, also known as primary biliary cirrhosis, is an autoimmune disease of the liver. The auto-immune disorder can have a number of symptoms such as abdominal pain, fever, nausea, vomiting, abdominal bloating, diarrhea, liver tenderness or enlargement, jaundice, and ascites.

Ticagrelor is utilized from one side of the planet to the other, particularly in districts like the United States, and the United Kingdom. Ticagrelor is typically suggested as the main treatment suggested for the avoidance of stroke and coronary episode in patients experiencing intense myocardial localized necrosis. This is on the grounds that, as per late investigations, this ticagrelor has more impact on the cerebrospinal liquid than other normally recommended drugs. The cerebrospinal liquid guides the sifting capacity of the sensory system, including the synapses and nerve motivations. At the point when the liquid is impeded, the neurons become delicate to improvements and experience torment or inconvenience, which might trigger an assault. Ticagrelor can be administered alone or in combination with certain anticoagulant (anti-coagulant) medicines. In patients who do not respond to other treatments, ticagrelor may be added to these medicines. Ticagrelor reduces blood pressure, reduces cholesterol, and improves the function of platelets in blood clotting. Other benefits of ticagrelor are reducing the frequency of recurrent stroke and preventing or reducing the damage caused by clots. In regions such as the US, the increasing prevalence of cardiovascular issues has increased the usage of ticagrelor. For instance, according to the U.S. Centers for Disease Control and Prevention, annually around 805,000 US residents suffer from a heart attack. A portion of the drugs that need a solution for use in treating AMI incorporate warfarin, niacin, amiodarone, and lovastatin, just as other antiplatelet, antipruritic, and antihypertensive meds. Ticagrelor was initially planned for use to treat malarial fever in patients whose lone ailment was coronary illness. As of late, notwithstanding, specialists have viewed this medication to be extremely helpful in the treatment of AMSI, or progressed cardiovascular breakdown. Since the primary driver of this condition is expanded tensio